Kaposi Sarcoma Associated Herpesvirus

• Kaposi Sarcoma Associated Herpesvirus (KSHV) is a gammaherpesvirus linked to several cancers, most notably Kaposi Sarcoma.
• KSHV infection is often lifelong and can remain latent, reactivating under certain conditions, particularly in immunocompromised individuals.
• Transmission occurs primarily through saliva, sexual contact, and organ transplantation.
• Beyond Kaposi Sarcoma, KSHV is also associated with primary effusion lymphoma and multicentric Castleman disease.
• Prevalence varies significantly globally, with higher rates observed in regions like sub-Saharan Africa.

What is Kaposi Sarcoma Associated Herpesvirus (KSHV)?

Kaposi Sarcoma Associated Herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8), is a gammaherpesvirus that is the causative agent of Kaposi Sarcoma. This virus was first identified in 1994 and has since been recognized for its oncogenic potential. KSHV establishes a lifelong infection in its host, typically remaining in a latent state where it replicates minimally and causes no immediate symptoms. However, under conditions of immune suppression, such as in individuals with HIV/AIDS or organ transplant recipients, the virus can reactivate, leading to the development of associated diseases.

Information about KSHV indicates that it primarily infects endothelial cells, B cells, and monocytes, integrating its genetic material into the host cell’s DNA. While the infection itself is often asymptomatic, its presence is a prerequisite for Kaposi Sarcoma. The global prevalence of KSHV varies widely; for instance, in the United States, KSHV is found in about 1-2% of the general population, whereas in parts of sub-Saharan Africa, up to 50% of people may be infected, according to the Centers for Disease Control and Prevention (CDC).

KSHV Transmission and Related Conditions

KSHV symptoms and transmission are crucial aspects of understanding its impact. The virus is primarily transmitted through close personal contact, with saliva exchange being a common route, particularly among children in endemic areas. Sexual contact is also a significant mode of transmission, especially among men who have sex with men. Other less common routes include blood transfusions, organ transplantation from an infected donor, and mother-to-child transmission, though this is rare. Most individuals infected with KSHV do not develop symptoms immediately; the infection often remains silent for many years.

The presence of KSHV is a necessary but not sufficient condition for developing Kaposi Sarcoma. The development of the disease is heavily influenced by the host’s immune status. Kaposi Sarcoma Herpesvirus causes not only Kaposi Sarcoma but also other lymphoproliferative disorders. These include primary effusion lymphoma (PEL), a rare and aggressive B-cell lymphoma that typically affects body cavities, and multicentric Castleman disease (MCD), a severe lymphoproliferative disorder characterized by enlarged lymph nodes and systemic inflammatory symptoms. These conditions highlight the diverse oncogenic capabilities of KSHV, particularly in individuals with compromised immune systems, where the virus can transition from latency to lytic replication, driving cellular proliferation and disease progression.